Approach to the Febrile Patient in the Intensive Care Unit

  • G. T. Dimopoulos


Fever occurs in approximately one-third of all medical patients during their hospital stay and in more than 90% of critically ill patients with severe sepsis [1]. According to the Society of Critical Care Medicine (SCCM) and the Infectious Diseases Society of America (IDSA), a temperature above 38.3°C (101°F) should be considered as fever necessitating a clinical assessment. The mean body temperature in healthy individuals is 36.8°C (98.2 °F), with a range of 35.6°C (96°F) to 38.2°C (100.8 °F) and a slight diurnal/circadian variation of between 0.5 and 1.0°C [2, 3]. Patients with elevated temperature in the ICU are in a closed monitoring system undergoing accurate and reproducible measurements using a variety of methods (instruments and techniques) at different body sites (Table 1.1) [4].


Acute Respiratory Distress Syndrome Ventilator Associate Pneumonia Malignant Hyperthermia Febrile Patient Acalculous Cholecystitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Cunha BA, Shea KW (1996) Fever in the intensive care unit. Infect Dis Clin North Am 10:185–209CrossRefPubMedGoogle Scholar
  2. 2.
    O’Grady NP, Barie PS, Bartlett J, Bleck T, Garvey G, Jacobi J, Linden P, Maki DG, Nam M, Pasculle MD, Triblett DL, Masur H (1998) Practice parameters for evaluating new fever in critically ill adult patients. Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine in collaboration with the Infectious Disease Society of America. Crit Care Med 26:392–408CrossRefPubMedGoogle Scholar
  3. 3.
    Mackoviak PA, Wassermann SS, Levine MM (1992) A critical appraisal of 98. 6 degrees F, the upper limit of the normal body temperature and other legacies of Carl Reinhold August Wunderlich. JAMA 268:1576–1580Google Scholar
  4. 4.
    Erikson RS, Kirklin SK (1993) Comparison of ear-based, bladder, oral and axillary methods for core temperature measurement. Crit Care Med 1:1528–1534CrossRefGoogle Scholar
  5. 5.
    Ipp M, Jaffre D (1993) Physicians’ attitudes toward the diagnosis and management of fever in children 3 months to 2 years of age. Clin Pediatr (Phila) 32:66–70CrossRefGoogle Scholar
  6. 6.
    Gozzoli V, Schottker P, Suter PM, Ricou B (2001) Is it worth treating fever in intensive care unit patients? Preliminary results from a randomized trial of the effect of external cooling. Arch Intern Med 161:121–123CrossRefPubMedGoogle Scholar
  7. 7.
    Leon L (2002) Cytokine regulation of fever: studies using gene knockout mice. J Appl Physiol 92:2648–2655PubMedGoogle Scholar
  8. 8.
    Saper CB, Breder CD (1994) The neurologic basis of fever. N Engl J Med 330:1880–1886CrossRefPubMedGoogle Scholar
  9. 9.
    Ryan M, Levy MM (2003) Clinical review: fever in intensive care unit patients. Crit Care 7:221–225CrossRefPubMedGoogle Scholar
  10. 10.
    Luheshi GN (1998) Cytokines and fever. Mechanisms and sites of action. Ann NY Acad Sci 856:83–89CrossRefPubMedGoogle Scholar
  11. 11.
    Simmons DL, Wagner D, Westover K (2000) Nonsteroidal anti-inflammatory drugs, acetaminophen, cyclooxygenase 2 and fever. Clin Infect Dis 31(Suppl 5):S211–S2CrossRefPubMedGoogle Scholar
  12. 12.
    Anderson KJ, Kuhn RE (1989) Elevated environmental temperature enhances immunity in experimental Chagas’ disease. Infect Immunol 57:13–17Google Scholar
  13. 13.
    Weinstein MP, Iannini PB, Stratton CW, Eickhoff TC (1978) Spontaneous bacterial peritonitis. A review of 28 cases with emphasis on improved survival and factors influencing prognosis. Am J Med 64(4):592–598CrossRefPubMedGoogle Scholar
  14. 14.
    Manthous CA, Hall JB, Olson D, Singh M, Chatila W, Pohlman A, Kushner R, Schmidt GA, Wood LD (1995) Effect of cooling on oxygen consumption in febrile critically ill patients. Am J Respir Crit Care Med 151(1):10–14PubMedGoogle Scholar
  15. 15.
    Ginsberg MD, Busto R (1998) Combating hyperthermia in acute stroke: a significant clinical concern. Stroke 29:529–534PubMedGoogle Scholar
  16. 16.
    Cunha BA (1994) Intensive care, not intensive antibiotics. Heart Lung 23:361–362PubMedGoogle Scholar
  17. 17.
    Cunha BA (1996) The clinical significance of fever patterns. Infect Dis Clin North Am 10:33–44CrossRefPubMedGoogle Scholar
  18. 18.
    Cunha BA, Tu RP (1988) Fever in the neurosurgical patient. Heart Lung 17:608–615PubMedGoogle Scholar
  19. 19.
    Stocchetti N, Rossi S, Roncati Zanier E, Colombo A, Beretta L, Citerio G (2002) Pyrexia in head-injured patients admitted to intensive care. Intens Care Med 28:1555–1562CrossRefGoogle Scholar
  20. 20.
    Barie PS, Fischer E (1995) Acute acalculous cholecystitis. J Am Coll Surg 180:232–234PubMedGoogle Scholar
  21. 21.
    Kiviniemi H, Makela JT, Autio R, Tikkakoski T, Leinonen S, Siniluoto T, Perala J, Paivansalo M, Merikanto J (1998) Percutaneous cholecystostomy in acute cholecystitis in high-risk patients: an analysis of 69 patients. Int Surg 83:299–302PubMedGoogle Scholar
  22. 22.
    Marik PE (2000) Fever in the ICU. Chest 117(3):855–869CrossRefPubMedGoogle Scholar
  23. 23.
    Wood AJJ (1998) Adverse drug reactions. In: Fauci AS, Braunwald E, Isselbacher KJ, et al. (eds) Harrison’s principles of internal medicine. McGraw-Hill, New York, NY, pp 422–430Google Scholar
  24. 24.
    Engoren M (1995) Lack of association between atelectasis and fever. Chest 107:81–84CrossRefPubMedGoogle Scholar
  25. 25.
    Fenwick JC, Cameron M, Naiman SC, Haley LP, Ronco JJ, Wiggs BR, Tweeddale MG (1994) Blood transfusion as a cause of leucocytosis in critically ill patients. Lancet 344(8926):855–856CrossRefPubMedGoogle Scholar
  26. 26.
    Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, Tolley EA (1999) Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 280:159–165CrossRefGoogle Scholar
  27. 27.
    Jarvis WR, Edwards JR, Culver DH, Hughes JM, Horan T, Emori TG, Banerjee S, Tolson J, Henderson T, Gaynes RP, et al. (1991) Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Am J Med 91(3B):185S–191SCrossRefPubMedGoogle Scholar
  28. 28.
    Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274(8):639–644CrossRefPubMedGoogle Scholar
  29. 29.
    Rello J, Diaz E, Rodriguez A (2005) Advances in the management of pneumonia in the intensive care unit: review of current thinking. Clin Microbiol Infect Suppl 5:30–38CrossRefGoogle Scholar
  30. 30.
    Rello J, Gallego M, Mariscal D, Sonora R, Valles J (1997) The value of routine microbial investigation in ventilator associated pneumonia. Am J Respir Crit Care Med 156:196–200PubMedGoogle Scholar
  31. 31.
    McConnell SA, Gubbins PO, Anaissie EJ (2004) Are antimicrobial-impregnated catheters effective? Replace the water and grab your washcloth, because we have a baby to wash. Clin Infect Dis 39(12):1829–1833CrossRefPubMedGoogle Scholar
  32. 32.
    Caines C, Gill MV, Cunha BA (1997) Non-Clostridium difficile nosocomial diarrhea in the intensive care unit. Heart Lung 26(1):83–84CrossRefPubMedGoogle Scholar
  33. 33.
    Meduri GU, Belenchia JM, Massie JD, Eltorky M, Tolley EA (1996) The role of gallium-67 scintigraphy in diagnosing sources of fever in ventilated patients. Intens Care Med 22:395–403CrossRefGoogle Scholar
  34. 34.
    Peres-Bota D, Rodriguez-Villalobos H, Dimopoulos G, Melot C, Vincent JL (2004) Potential risk factors for infection with Candida spp. in critically ill patients. Clin Microbiol Infect 10(6):550–555CrossRefPubMedGoogle Scholar
  35. 35.
    Jaber S, Chanques G, Borry J, Souche B, Verdier R, Perrigault PF, Eledjam JJ (2005) Cytomegalovirus infection in critically ill patients: associated factors and consequences. Chest 127:233–241CrossRefPubMedGoogle Scholar
  36. 36.
    Laupland KB, Bagshaw SM, Gregson DB, Kirkpatrick AW, Ross T, Church DL (2005) Intensive care unit-acquired urinary tract infections in a regional critical care system. Crit Care 9(2):R60–65CrossRefPubMedGoogle Scholar
  37. 37.
    Gaynes R, Edwards JR (2005) National Nosocomial Infections Surveillance System Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 41(6):848–854CrossRefPubMedGoogle Scholar
  38. 38.
    Pronovost PJ, Holzmueller CG (2004) Partnering for quality. J Crit Care 19(3):121–129CrossRefPubMedGoogle Scholar
  39. 39.
    Mackowiak PA (2000) Physiological rationale for suppression of fever. Clin Infect Dis 31(Suppl 5):S185–189CrossRefPubMedGoogle Scholar
  40. 40.
    Gozzoli V, Treggiari MM, Kleger GR, Roux LP, Fathi M, Pichard C, Romand JA (2004) Randomized trial of the effect of antipyresis by metamizol, propacetamol or external cooling on metabolism, hemodynamics and inflammatory response. Intens Care Med 30(3):401–407CrossRefGoogle Scholar
  41. 41.
    Mackowiak PA, Boulant JA (1996) Fever’s glass ceiling. Clin Infect Dis 22:525–536PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2007

Authors and Affiliations

  • G. T. Dimopoulos
    • 1
  1. 1.Department of Intensive Care, ATTIKO University Hospital, Medical SchoolUniversity of AthensAnixi, Attiki, AthensGreece

Personalised recommendations